Large-scale testing (Phase 3)Study completedNCT02207816
What this trial is testing
An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa
Who this might be right for
Malaria
GlaxoSmithKline 3,084